New drug KESONOTIDE™ enters human trials for multiple cancers
NCT ID NCT06926075
First seen Oct 01, 2025 · Last updated May 23, 2026 · Updated 23 times
Summary
This study tests a new experimental drug, KESONOTIDE™, in people with advanced solid tumors like prostate, breast, lung, ovarian, pancreatic, skin cancer, or glioblastoma. The main goal is to check the drug's safety and find the right dose. About 80 adults will take part in two phases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
South Western Sydney Local Health District
RECRUITINGLiverpool, New South Wales, 2170, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Southside Cancer Centre
RECRUITINGMiranda, New South Wales, 2228, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
St George Private Hospital
RECRUITINGKogarah, New South Wales, 2217, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.